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ABSTRACT
A simple and sensitive extractive spectrophotometric method has been described for the assay of cetirizine dihydrochloride in
pure and different pharmaceutical preparations. The method was based on the formation of the ion-pair complex from the reaction
between cetirizine dihydrochloride and methyl orange in pH 4.0, which gave a yellow color after chloroform extraction and exhibited a maximum absorbance at 424.5 nm. Beer's law was obeyed in the concentration range of 2.5 - 20 μg/mL. The method was
tested and validated for various parameters according to ICH guidelines. The detection and quantification limits were 1.0 and
3.0 μg/mL, respectively. The proposed method was successfully applied for the determination of cetirizine dihydrochloride in pharmaceutical preparations. The results demonstrated that the procedure was accurate, precise and reproducible while statistical analysis of the obtained results showed no significant difference between the proposed method and reference method. No interference
was observed for common pharmaceutical preparations.
Key words: spectrophotometry, pharmaceuticals, methyl orange, ion pair

INTRODUCTION
Cetirizine dihydrochloride (CE) is an orally active
and selective H1-receptor antagonist. Its chemical name
is (±)- [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid, dihydrochloride (Figure 1).
It is a non-sedating type histamine H1-receptor antagonist used in symptomatic treatment of seasonal rhinitis,
conjunctivitis, perennial allergic rhinitis, and pruritus
and urticaria of allergic origin(1).
Various analytical techniques have been employed
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Figure 1. Chemical structure of cetirizine dihydrochloride.
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for the determination of CE in pharmaceutical preparations such as spectrophotometry (2,3), high performance
thin layer chromatography (HPTLC)(4), high performance liquid chromatography (HPLC)(5,6) and liquid
chromatography-mass spectrometry (LC/MS)(7). CE has
been determined in biological fluids by HPLC(8-11) and
liquid chromatography - tandem mass spectrometry(12).
The present study has shown the development of
an accurate, reproducible, fast and adequately sensitive
extractive spectrophotometric method based on an ionpair complex formed between CE and an anionic dye,
methyl orange. An important advantage of the extractive spectrophotometric method is that it can be applied
to the determination of individual compounds in a
multi-component mixture. Unlike gas chromatographic
(GC) and HPLC procedures, the instrument is relatively
simple and affordable. The sensitivity (in terms of molar
absorptivity) and precision (in terms of relative standard
deviation, RSD) of the methods are suitable for the determination of the drug in pure and mixed dosage forms.
The reagents utilized in the proposed method is relatively
cheap and readily available, and the procedure does not
involve any critical reaction condition or tedious sample
preparation. These advantages, coupled with reasonable
accuracy and precision, render the methods suitable
for routine quality control. The proposed method was
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applied to the determination of CE in pharmaceutical
formulations. No interference was observed in the assay
of CE from common excipients in levels found in pharmaceutical formulations. The proposed method was validated by statistical data.

MATERIALS AND METHODS

Zyrtec® tablets) were crushed into powder, and the
average weight of the tablets was determined. An accurate weight equivalent to 100 mg of CE was dissolved in
50 mL of methanol with shaking for 30 min and filtered.
The filtrate was diluted to 100 mL with methanol in a
100-mL measuring flask to give 1.0 mg/mL of stock solution. An aliquot of the diluted drug solution was treated
as described under Section IV.

I. Materials

VI. Method Validation

Pure powder of CE was obtained from Sigma (St.
Louis, MO, USA). Allerset ® and Zyrtec® tablets were
obtained from a pharmacy. Methyl orange (MO) was
purchased from Merck (Darmstadt, Germany). Solvents
and other chemicals were of analytical grade (Merck,
Darmstadt, Germany). Water was prepared by using
aquaMAX TM ultra (Young instrument, Korea) water
purification system.

Typical analytical performance characteristics for
the validation of procedures according to ICH Q2 guidelines were described in this study, including specificity,
linearity, limit of detection, limit of quantification, precision, accuracy, recovery and robustness (13).

II. Preparation of Stock and Standard Solutions

(I) Specificity
To assess the specificity of the method, the effect of
diluents, excipients and additives which often accompany
CE in its dosage forms (lactose, titanium dioxide, cellulose and microcrystalline) was studied.

A stock solution of CE (1.0 mg/mL) was prepared
in methanol. A working standard solution was prepared
by diluting the stock standard solution with methanol
(100 μg/mL). Methyl orange (MO) solutions (0.2% w/v)
were prepared in water. Phthalate buffer was prepared
by dissolving 1.280 g of potassium hydrogen phthalate in
50 mL of water. The pH was adjusted to 4.0 with 0.2 M HCl
solution and the volume was made up to 250 mL with water.

The calibration graph is described by the calibration
equation of A = aC + b, where A is the absorbance, a is
the slope, b is the intercept and C is the concentration of
the ion-pair complex product.

III. Apparatus

(III) Limits of Detection (LOD) and Quantification (LOQ)

All spectrophotometric measurements were performed
on a Shimadzu UV-160A UV-Visible spectrophotometer
with 1-cm glass cells. UV-visible spectra were automatically obtained by Shimadzu UV-160A system software.

The LOD and LOQ of CE by the proposed method
were determined using calibration standards. LOD and
LOQ were calculated as 3.3r/S and 10r/S, respectively,
where r is the standard deviation of y-intercept of the regression equation and S is the slope of the calibration curve.

IV. General Procedure
Aliquots of 0.25 - 2.0 mL of the standard solution
(100 μg/mL) were transferred to 10-mL calibrated flasks.
One milliliter of potassium hydrogen phthalate buffer
(pH 4.0) was added, followed by 0.5 mL of reagent solution (0.2% w/v). After 2 min vortexing the tubes were
allowed to separate the two layers. The complex was
extracted three times with 3 mL of chloroform. After
the phases had been separated by centrifugation, the
combined extracts were adjusted to 10 mL with the same
solvent. The absorbance of the yellow-colored complex
was measured at 424.5 nm, against a corresponding
reagent blank similarly prepared. All measurements were
made at room temperature (25 ± 2°C).
V. Procedure for the Assay of the Tablets
The contents of twenty tablets (Allerset ® and

(II) Linearity

(IV) Accuracy
To determine the accuracy of the proposed method,
different levels of drug concentrations (low concentration, medium concentration, and high concentration) in
both media were prepared from independent stock solutions and analyzed (n = 6). Accuracy was assessed as the
relative mean error.
(V) Precision
Precision or repeatability was determined by using
different drug concentrations prepared from independent stock solutions and analyzed (n = 6). Inter-day and
intra-day variations were taken to determine the intermediate precision of the proposed method. Different levels
of drug concentrations in triplicates were prepared thrice
in a day and studied for intra-day variation. The same
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method was followed for three different days to study
inter-day variation (n = 6).
(VI) Recovery
The recovery of the proposed method was determined
using the standard addition technique, by adding a known
amount of standard at three different levels to the preanalysed sample.
(VII) Robustness

the above reaction was judged based on the observation
of complete colour development between 1 and 2 min
and remained stable for one day. It was observed that
absorbance reached a maximum at 25°C (room temperature). The optimum reaction time was studied from 1.0
to 15.0 min by following the color 2.0 min and at room
temperature. The reaction time was quite short compared
with other methods (2-12) .
(III) Effect of Temperature
The absorbance-temperature curve of the reaction

The robustness of the proposed method was determined by (a) changing the pH of the media by ± 0.1 unit and
(b) changing the concentration of the reagent by ± 0.1 unit.

I. Absorption Spectra
The nitrogenous drug was present in positivelycharged protonated form, while anionic dyes of sulphonphthalein group were present mainly in anionic form
at pH ≥ 3. Thus, when treated with an acid dye at pH 4.0
of potassium hydrogen phthalate buffer, a yellow ion-pair
complex (extracted with chloroform) was formed. The
absorption spectra of the ion-pair complex, which was
formed between CE and MO, were measured in the range
of 300-600 nm against the blank solution (Figure 2).
The ion-pair complex showed maximum absorbance at
424.5 nm. The optimum reaction conditions for the determination of the ion-pair complex were established.
II. Optimum Reaction Conditions for Complex Formation
The reaction conditions of the method was carefully
studied to achieve complete reaction, highest sensitivity and maximum absorbance. Reaction conditions for
the formation of the ion-pair complex were optimized
by studying preliminary experiments involving pH of
buffer, type of organic solvent, volume of the dye and
shaking time for the extraction of ion-pair complexes.
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Figure 2. Absorption spectra of CE-MO complex (15 µg/mL).
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Figure 3. Effect of pH on the reaction of CE with MO.

(I) Effect of pH

(II) Effect of Time
The effect of time (Figure 4) and temperature on
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The effect of pH was studied by extracting the
colored complexes in the presence of various buffers such
as KCl-HCl (pH 1.5 - 4.5), NaOAc-HCl (pH 2.0 - 5.0),
and potassium hydrogen phthalate-HCl (pH 2.0 - 5.0).
The maximum color intensity and highest absorbance
value were observed in potassium hydrogen phthalateHCl buffer of pH 4.0 (Figure 3).
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Figure 4. Effect of time on the reaction of CE with MO.
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between CE and MO was constructed at λ max and the
results are shown in Figure 5. The absorbance of the
extracted ion-pairs was measured at 20 - 60°C and at
room temprature. Figure 5 shows that the absorbance
generally increased with temperature and peaked at 25°C
(room temperature) using MO reagent. The temperature
fluctuated slightly about this temperature. The optimum
reaction time was studied from 1.0 to 15.0 min. Complete
color intensity was attained 2 min at room temperature.
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(IV) Effect of MO Concentration
The effect of the concentration of the dye on the
intensity of the color developed at the selected wavelength and constant drug concentration was tested
using different volumes of MO (0.5 - 4.0 mL). It was
observed that 0.5 mL of 0.2% (w/v) MO was necessary
for maximum color development of the ion-pair complex.
Above this volume, the absorbance remained constant.
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Figure 5. Effect of temperature on the reaction between CE and MO.
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Solvents like n-butanol and benzene could not be used
for the extraction of the ion-pairs formed, while acetone,
dichloromethane, methylene chloride and chloroform
extracted those ion-pairs quantitatively. The molar absorptivity value for the ion-pair in chloroform using MO was
ε = 1.5 × 104 L/mol/Xcm at λ max = 424.5 nm. This value
made chloroform a suitable media for extraction.
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(VI) Stoichiometric Ratio
Job’s Method of Continuous Variation(14) of equimolar
solutions was employed. A 2.0 × 10 −4 M standard solution of drug and 2.0 × 10 −4 solution of CE were used. A
series of solutions was prepared in which the total volume
of drug and reagent was kept at 10 mL. The absorbance
was measured at the optimum wavelength. The molar ratio
of the reagent (drug : dye) in the ion-pair complex was
determined by the Method of Continuous Variation (Job’s
Method) and the results indicated that 1 : 2 (drug : dye)
was the optimum ratio for the reaction (Figure 6).
III. Method Validation
(I) Specificity
A study of some potential interfering substances
in the spectrophotometric determination of CE was
performed by selecting some excipients commonly
used in tablet formulations. Samples containing a fixed
amount of CE (20 µg/mL) and variable concentrations
of excipients were analyzed. There was no interference
from most of the common ingredients such as lactose,
titanium dioxide, cellulose and microcrystalline. It was
shown that these compounds did not interfere with the
proposed method.
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Figure 6. Effect of molar ratio of MO to CE on the reaction.

(II) Linearity
A calibration graph was constructed by measuring
the absorbance at five concentration levels. It showed a
linear response of absorbance in relation to the concentration of CE over the range of 2.5 - 20 μg/mL. As shown by
the data, the method was much more sensitive than most
of the reported methods(2-3,6). The representative linear
equations relating A (absorbance) to C (concentration
μg/mL) was A = 0.034C + 0.114 (r = 0.9998) (Table 1).
(III) Accuracy and Precision
The intra-day and inter-day relative standard deviation
(RSD) values obtained by the proposed method were found
to be within 0.36 - 2.38% for CE. Accuracy of the method
expressed as relative mean error (RME) was between 2.0 7.0%. The statistical parameters are given in Table 2.
(IV) Limits of Detection and Quantification
LOD and LOQ were found to be 1.0 and 3.0 µg/mL,
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Table 1. Statistical data of the regression equations for determination of CE
Parameters

2.5 - 20

Molar absorptivity (L/mol/Xcm)

1.5 × 104

Sandell’s sensitivity (μg/cm2)

2.6 × 10-2

Regression equation

Proposed
method

Spectrophotometric method

Linearity range (μg/mL)

Table 3. Determination of CE by standard addition method
Concentration (μg/mL)
Theoretical

Spiked

5.0

5.0

98.40 ± 2.28

5.0

10.0

98.70 ± 0.67

5.0

15.0

99.30 ± 0.45

A = 0.034C + 0.114

Intercept (b)

0.114

Slope (a)

0.034

Correlation coefficient (r)

0.9998

Recovery ±
RSD%

Table 2. Intra- and inter-day precision and accuracy of the assay for CE
Nominal concentration
(µg/mL )

No. of replicates
(n)

Found concentration
(mean ± SD, µg/mL)

Precision
(RSD %)

Accuracy
(RME %)

2.5

6

2.45 ± 0.041

1.67

-2.00

10

6

9.64 ± 0.056

0.58

-3.60

20

6

19.1 ± 0.069

0.36

-4.50

2.5

6

2.40 ± 0.057

2.38

-4.0

10

6

9.57 ± 0.068

0.71

-4.3

20

6

18.6 ± 0.071

0.38

-7.0

Intra-day

Inter-day

respectively. These values were much lower than those
obtained by many other methods.

Table 4. Robustness of the proposed method
Conditions

(V) Recovery

Mean ± S.D.
CE-MO ion pair (10.0 μg/mL)

The recoveries are given in Table 3. The observed
CE values were in good agreement with the theoretical
values in the three model mixtures. The recovery data
ranged from 98.40 to 99.30% in the proposed method.

Optimum

(VI) Robustness

0.3% w/v

9.83 ± 0.341

0.1% w/v

9.86 ± 0.323

The robustness of the method was checked by
examining the effect of slight condition changes on the
quantification result. No significant difference could be
observed. The results are shown in Table 4.
VI. Determination of CE in Pharmaceutical Formulations
The applicability of the developed method was

9.88 ± 0.231

Dye concentration

Dye pH
4.1

9.86 ± 0.421

3.9

9.81 ± 0.312
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checked by analyzing two commercially available pharmaceutical formulations. The formulations selected
were Allerset ® and Zyrtec® tablets. Comparing the
results obtained by the proposed method with the reference method(6) using the t-test for accuracy and F-test
for precision assessment, the calculated values did not
exceed the corresponding theoretical values indicating
insignificant differences between the results and showing
robustness of the proposed procedure (Table 5).

ConclusIonS
The proposed method made use of a simple reagent,
which most ordinary analytical laboratories can afford.
The method is sufficiently sensitive to permit determinations as low as 1.0 µg/mL. Unlike GC and HPLC
procedures, the spectrophotometer is relatively simple
to handle and affordable. The proposed method is
simple, precise, accurate and convenient. Hence, the
proposed methods should be useful for routine quality
control purposes.
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